{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "68016-740",
      "generic_name": "Dextromethorphan HBr, Guaifenesin",
      "labeler_name": "PHARMACY VALUE ALLIANCE LLC",
      "brand_name": "Premier Value Maximum Strength",
      "brand_name_suffix": "Maximum Strength",
      "active_ingredients": [
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "20 mg/20mL"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "400 mg/20mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "68016-740-04",
          "description": "1 BOTTLE in 1 CARTON (68016-740-04)  / 118 mL in 1 BOTTLE",
          "marketing_start_date": "20190325",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "PHARMACY VALUE ALLIANCE LLC"
        ],
        "rxcui": [
          "1020138"
        ],
        "spl_set_id": [
          "46bf124a-a44f-4066-b936-852d46da8f40"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000193956",
          "N0000008867",
          "N0000009560"
        ],
        "pharm_class_epc": [
          "Expectorant [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Respiratory Secretion Viscosity [PE]",
          "Increased Respiratory Secretions [PE]"
        ],
        "unii": [
          "9D2RTI9KYH",
          "495W7451VQ"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "SOLUTION",
      "spl_id": "54025a67-fd48-4ed1-a284-0a87e6755041",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20190325",
      "product_id": "68016-740_54025a67-fd48-4ed1-a284-0a87e6755041",
      "application_number": "M012",
      "brand_name_base": "Premier Value",
      "pharm_class": [
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]"
      ]
    }
  ]
}